Overview
IGC market data
Price History
IGC price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.05 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.48 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -552.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.24 – $0.50 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $29.2M · P/B 3.52 · P/S 24.65.
Company News
IGC Pharma Says Phase 2 CALMA Trial Of IGC-AD1 In Alzheimer's Agitation Has Randomized 160 Participants To Date, With Topline Results Expected In Q4 2026Benzinga · Aug 11, 2026, 12:36 PM
'THC And CBD From Marijuana Reduces Agitation In 9 Out Of 10 People With Alzheimer’s Or Other Dementia, Study Shows' - Marijuana MomentBenzinga · Jul 20, 2026, 3:12 PM
8-K filing — IGC Pharma, Inc. (IGC)SEC EDGAR · Jul 13, 2026, 10:11 PM
IGC Pharma Says CEO Ram Mukunda And Principal Financial Officer Claudia Grimaldi Purchase Aggregate Of 4,274,853 Shares Directly From Company At $0.27/ShrBenzinga · Jul 7, 2026, 1:10 PM
IGC Pharma Launches AI-Powered Data Harmonization Platform To Accelerate Alzheimer’s Research And Drug DiscoveryBenzinga · Jun 23, 2026, 12:40 PM
'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana MomentBenzinga · Jun 5, 2026, 12:00 PM
IGC Pharma Announces Addition Of Icahn School Of Medicine At Mount Sinai In New York As Clinical Site In Phase 2 CALMA Trial Evaluating IGC-AD1 For Agitation Associated With Alzheimer's DiseaseBenzinga · Jun 2, 2026, 12:41 PM
"Marijuana Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows" - Marijuana MomentBenzinga · May 29, 2026, 3:15 PM